SB Medical Limited Filleted accounts for Companies House (small and micro)
SB Medical Limited Filleted accounts for Companies House (small and micro)
COMPANY REGISTRATION NUMBER:
06929389
|
|
|
|
Abridged Statement of Financial Position |
2021 |
2020 |
||
Note |
£ |
£ |
£ |
Fixed assets
Investments |
4 |
|
|
|
Current assets
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
--------- |
--------- |
||
|
|
||
Creditors: amounts falling due within one year |
|
|
|
--------- |
--------- |
||
Net current assets |
|
|
|
--------- |
--------- |
||
Total assets less current liabilities |
|
|
|
--------- |
--------- |
||
Net assets |
|
|
|
--------- |
--------- |
||
Capital and reserves
Called up share capital |
|
|
|
Profit and loss account |
|
|
|
--------- |
--------- |
||
Shareholders funds |
|
|
|
--------- |
--------- |
||
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements
.
|
Abridged Statement of Financial Position (continued) |
These abridged financial statements were approved by the
board of directors
and authorised for issue on
24 October 2021
, and are signed on behalf of the board by:
|
|
Director |
Director |
Company registration number:
06929389
|
Notes to the Abridged Financial Statements |
Year ended 31 March 2021
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 90 Copse Hill, Harlow, Essex, CM19 4PP.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
Revenue recognition
Income tax
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in joint ventures
Impairment of fixed assets
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.
Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.
Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
4.
Investments
£ |
|
Cost |
|
At 1 April 2020 and 31 March 2021 |
|
--------- |
|
Impairment |
|
At 1 April 2020 and 31 March 2021 |
– |
--------- |
|
Carrying amount |
|
At 31 March 2021 |
|
--------- |
|
At 31 March 2020 |
|
--------- |
|
5.
Related party transactions
There were no transactions with related parties that are required to be disclosed under Financial Reporting Standard for smaller entities.